WallStSmart

Aspire BioPharma, Inc. (ASBP)vsAutoZone Inc (AZO)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

AutoZone Inc generates 20825781% more annual revenue ($20.34B vs $97,660). AZO leads profitability with a 12.7% profit margin vs 0.0%. AZO earns a higher WallStSmart Score of 57/100 (C).

ASBP

Avoid

22

out of 100

Grade: F

Growth: 4.3Profit: 4.5Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -83.49

AZO

Buy

57

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 4.7Quality: 5.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASBP.

AZOSignificantly Overvalued (-78.5%)

Margin of Safety

-78.5%

Fair Value

$2092.80

Current Price

$3156.76

$1063.96 premium

UndervaluedFair: $2092.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASBP1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

AZO3 strengths · Avg: 9.0/10
Debt/EquityHealth
-4.9710/10

Conservative balance sheet, low leverage

Market CapQuality
$50.47B9/10

Large-cap with strong market position

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Areas to Watch

ASBP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.80M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

AZO2 concerns · Avg: 3.0/10
Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ASBP

The strongest argument for ASBP centers on Price/Book.

Bull Case : AZO

The strongest argument for AZO centers on Debt/Equity, Market Cap, Operating Margin. PEG of 1.31 suggests the stock is reasonably priced for its growth.

Bear Case : ASBP

The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.

Bear Case : AZO

The primary concerns for AZO are Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

AZO carries more volatility with a beta of 0.40 — expect wider price swings.

AZO is growing revenue faster at 5.6% — sustainability is the question.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AZO scores higher overall (57/100 vs 22/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspire BioPharma, Inc.

CONSUMER CYCLICAL · AUTO PARTS · USA

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

Visit Website →

AutoZone Inc

CONSUMER CYCLICAL · AUTO PARTS · USA

AutoZone, Inc. is an American retailer of aftermarket automotive parts and accessories, the largest in the United States.

Visit Website →

Want to dig deeper into these stocks?